article Open AccessTop 1% cited
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Leukemia · 2011 · Vol. 26(1) · pp. 149–157
Shaji Kumar✉(Mayo Clinic in Arizona)J H Lee(Deleted Institution)Juan José Lahuerta(Hospital Universitario 12 De Octubre)Gareth J. Morgan(Royal Marsden Hospital)Paul G. Richardson(Boston University)John Crowley(Cancer Research And Biostatistics)J. Haessler(Cancer Research And Biostatistics)J Feather(Boston University)Antje Hoering(Cancer Research And Biostatistics)Philippe MoreauXavier Leleu(Hôpital Claude Huriez)Cyrille Hulin(Centre Hospitalier Régional et Universitaire de Nancy)Saskia K. Klein(Erasmus MC)Pieter Sonneveld(Erasmus MC)David S. Siegel(Hackensack University Medical Center)Joan Bladé(Hospital Clínic de Barcelona)Hartmut Goldschmidt(Heidelberg University)Sundar Jagannath(Mount Sinai Hospital)Jesús F. San Miguel(Complejo Hospitalario de Salamanca)Robert Z. Orlowski(The University of Texas MD Anderson Cancer Center)Antonio Palumbo(University of Turin)Orhan Sezer(Universität Hamburg)S. Vincent Rajkumar(Mayo Clinic in Florida)Brian G.M. Durie(Cedars-Sinai Medical Center)on behalf of the International Myeloma Working GroupInternational Myeloma Working GroupNiels AbildgaardRafat AbonourR. AlexanianMelissa AlsinaC Anderson KennethMichael AttalHervé Avet‐LoiseauAshraf BadrosDalsu BarisBart BarlogieRégis BatailleMeral BeksaçAndrew BelchDina Ben‐Yehuda(University of Turin)Bill BensingerP. Leif Bergsagel(Hospital Clínic de Barcelona)Jenny BirdJoan Bladé(Hospital Clínic de Barcelona)Mario BoccadoroMichèle CavoAsher Chanan‐KhanWen Ming ChenTony ChildChor Sang ChimWee Joo Chng(Cancer Research And Biostatistics)Ray ComenzoJohn Crowley(Cancer Research And Biostatistics)William S. DaltonFaith E. DaviesCármino Antônio De SouzaMichel DelforgeMeletios Α. DimopoulosAngela DispenzieriJohannes Drach(Cedars-Sinai Medical Center)Matthew T. DrakeBrian G.M. Durie(Cedars-Sinai Medical Center)Hermann EinseleT. FaconDorotea FantlJean‐Paul FermandRafaël FonsecaGösta GahrtonRamón García‐SánzChristina GasparettoMorie A. GertzJohn Gibson(Heidelberg University)Sergio GiraltHartmut Goldschmidt(Heidelberg University)Philip R. GreippRoman HájekIzhar HardanParameswaran HariJean‐Luc HarousseauHiroyuki HataYutaka Hattori(Cancer Research And Biostatistics)Tom HeffnerJoy HoVânia HungriaShinsuke Ida(Mount Sinai Hospital)Peter JacobSundar Jagannath(Mount Sinai Hospital)Hans Erik JohnsenJian HouDouglas JoshuaArtur JurczyszynMichio Kawano(Mayo Clinic in Florida)Nicolaus KrögerShaji Kumar(Mayo Clinic in Arizona)Robert A. Kyle(Hospital Universitario 12 De Octubre)Martha Q. LacyJuan José Lahuerta(Hospital Universitario 12 De Octubre)Ola Landgren(Deleted Institution)Jacob P. Laubach(Hôpital Claude Huriez)Jae Hoon Lee(Deleted Institution)Xavier Leleu(Hôpital Claude Huriez)Suzanne LentzschHenk M. LokhorstSagar LonialHeinz LudwigÂngelo MaiolinoMaría‐Victoria MateosJayesh MehtaUlf‐Henrik MellqvistGiampaolo MerliniJoseph MıkhaelA Rodriguez Morales(Royal Marsden Hospital)Philippe MoreauGareth J. Morgan(Royal Marsden Hospital)Hareth NariNikhil C. MunshiRubén NiesvizkyAmara Nouel(The University of Texas MD Anderson Cancer Center)Yana Novis(University of Turin)Robert Z. Orlowski(The University of Texas MD Anderson Cancer Center)Antonio Palumbo(University of Turin)S PavlovskyLinda M. PilarskiRaymond Powles(Mayo Clinic in Florida)Noopur RajeS. Vincent Rajkumar(Mayo Clinic in Florida)Donna Reece(Boston University)Tony ReimanPaul G. Richardson(Dana-Farber Cancer Institute)David Roodman(Complejo Hospitalario de Salamanca)Laura Rosiñol(Universität Hamburg)Jesús F. San MiguelOrhan Sezer(Universität Hamburg)Jatin J. ShahJohn D. ShaughnessyKazuyuki Shimizu(Hackensack University Medical Center)Chaim ShustikDavid S. Siegel(Hackensack University Medical Center)Seema SinghalPieter Sonneveld(Erasmus MC)Andrew SpencerEdward A. StadtmauerKeith StewartEvangelos TerposPatrizia TosiGuido TricotIngemar TuressonBen Van CampBrian Van NessIvan Van RietIsabelle Vande BroekKarin VanderkerkenRobert VescioDavid H. VesoleAnders WaageMichael WangDonna WeberJan WestinKeith WheatleyJeffrey A. Zonder
Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisMultiple myelomaBortezomibMedicineInternal medicineOncologyLenalidomideMulticenter studyRandomized controlled trial
MeSH terms
AdultAgedAged, 80 and overAntineoplastic AgentsFemaleHumansImmunologic FactorsMaleMiddle AgedMultiple MyelomaRecurrenceSurvival AnalysisDisease Progression
Citations
720
FWCI
23.33
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
References
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
British Journal of Haematology · 1998 · 1,525 citations
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Leukemia · 2009 · 875 citations
Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Mayo Clinic Proceedings · 2009 · 623 citations
International uniform response criteria for multiple myeloma
Leukemia · 2006 · 2,623 citations
Improved survival in multiple myeloma and the impact of novel therapies
Blood · 2007 · 2,238 citations
International Staging System for Multiple Myeloma
Journal of Clinical Oncology · 2005 · 2,894 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.